Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass Balance Study of [14C]-SK-1405 in Healthy Males
NCT02846181Phase 1Completed
- Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Start
- Jul 2016
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of SK-1405 in pruritus, sponsored by Sanwa Kagaku Kenkyusho Co., Ltd. Primary endpoints: 14C radioactivity concentration excreted in urine, 14C radioactivity concentration excreted in faeces and 2 more. Started Jul 2016; status: completed.
02
Drugs
SK-1405
03
Conditions
pruritus
Beyond the preview
Go deeper on NCT02846181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02846181.